178 related articles for article (PubMed ID: 30119986)
1. Pyelonephritis treatment in the community emergency department: Cephalosporins vs. first-line agents.
Vogler S; Pavich E
Am J Emerg Med; 2018 Nov; 36(11):2054-2057. PubMed ID: 30119986
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.
Talan DA; Stamm WE; Hooton TM; Moran GJ; Burke T; Iravani A; Reuning-Scherer J; Church DA
JAMA; 2000 Mar 22-29; 283(12):1583-90. PubMed ID: 10735395
[TBL] [Abstract][Full Text] [Related]
3. Assessment of nationally recommended antibiotics for treatment of UTI in U.S.-Mexico border emergency departments.
Davis WH; Magee MR; Monks SM; Geno KA; Crawford SB
Am J Emerg Med; 2022 Nov; 61():12-17. PubMed ID: 36027632
[TBL] [Abstract][Full Text] [Related]
4. Comparing outcomes among outpatients treated for pyelonephritis with oral cephalosporins versus first-line agents.
Fosse PE; Brinkman KM; Brink HM; Conner CE; Aden JK; Giancola SE
Int J Antimicrob Agents; 2022 Apr; 59(4):106560. PubMed ID: 35259485
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic selection and isolate susceptibility profile in patients who failed ciprofloxacin or TMP-SMX for pyelonephritis.
Truong WR; Won KJ; Yamaki J
Am J Emerg Med; 2019 Oct; 37(10):1980-1981. PubMed ID: 31023585
[No Abstract] [Full Text] [Related]
6. Effect of Cephalexin Plus Trimethoprim-Sulfamethoxazole vs Cephalexin Alone on Clinical Cure of Uncomplicated Cellulitis: A Randomized Clinical Trial.
Moran GJ; Krishnadasan A; Mower WR; Abrahamian FM; LoVecchio F; Steele MT; Rothman RE; Karras DJ; Hoagland R; Pettibone S; Talan DA
JAMA; 2017 May; 317(20):2088-2096. PubMed ID: 28535235
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
Talan DA; Krishnadasan A; Abrahamian FM; Stamm WE; Moran GJ;
Clin Infect Dis; 2008 Nov; 47(9):1150-8. PubMed ID: 18808361
[TBL] [Abstract][Full Text] [Related]
8. Predictors of receipt of a fluoroquinolone versus trimethoprim-sulfamethoxazole for treatment of acute pyelonephritis in women in Manitoba, Canada.
Carrie AG; Metge CJ; Collins DM; Harding GK; Zhanel GG
Pharmacoepidemiol Drug Saf; 2004 Dec; 13(12):863-70. PubMed ID: 15386718
[TBL] [Abstract][Full Text] [Related]
9. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
10. Standard versus newer antibacterial agents in the treatment of severe acute exacerbation of chronic obstructive pulmonary disease: a randomized trial of trimethoprim-sulfamethoxazole versus ciprofloxacin.
Nouira S; Marghli S; Besbes L; Boukef R; Daami M; Nciri N; Elatrous S; Abroug F
Clin Infect Dis; 2010 Jul; 51(2):143-9. PubMed ID: 20536364
[TBL] [Abstract][Full Text] [Related]
11. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli.
Moreno E; Prats G; Sabaté M; Pérez T; Johnson JR; Andreu A
J Antimicrob Chemother; 2006 Feb; 57(2):204-11. PubMed ID: 16390858
[TBL] [Abstract][Full Text] [Related]
12. Retrospective Comparison of Cefdinir, Cephalexin, and Sulfamethoxazole-Trimethoprim in the Treatment of Outpatient Pediatric Urinary Tract Infections.
Cardinale B; Zembles TN; Ray K; Bushee G; Liegl M; Simpson P; Mitchell M
Clin Pediatr (Phila); 2023 Jan; 62(1):47-54. PubMed ID: 35861216
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis.
Ko JH; Kang CI; Cornejo-Juárez P; Yeh KM; Wang CH; Cho SY; Gözel MG; Kim SH; Hsueh PR; Sekiya N; Matsumura Y; Lee DG; Cho SY; Shiratori S; Kim YJ; Chung DR; Peck KR
Clin Microbiol Infect; 2019 May; 25(5):546-554. PubMed ID: 30448331
[TBL] [Abstract][Full Text] [Related]
14. National trends in emergency department antibiotic prescribing for elders with urinary tract infection, 1996-2005.
Caterino JM; Weed SG; Espinola JA; Camargo CA
Acad Emerg Med; 2009 Jun; 16(6):500-7. PubMed ID: 19245373
[TBL] [Abstract][Full Text] [Related]
15. Cephalosporins for the treatment of uncomplicated pyelonephritis: A systematic review.
Zimmerman DE; Tomas M; Miller D; Tomcsanyi L; Signorella C; Montepara CA; Covvey JR; Guarascio AJ
J Am Pharm Assoc (2003); 2023; 63(5):1461-1471. PubMed ID: 37414282
[TBL] [Abstract][Full Text] [Related]
16. Empiric outpatient therapy with trimethoprim-sulfamethoxazole, cephalexin, or clindamycin for cellulitis.
Khawcharoenporn T; Tice A
Am J Med; 2010 Oct; 123(10):942-50. PubMed ID: 20920697
[TBL] [Abstract][Full Text] [Related]
17. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
Fox MT; Melia MT; Same RG; Conley AT; Tamma PD
Am J Med; 2017 Jul; 130(7):842-845. PubMed ID: 28216442
[TBL] [Abstract][Full Text] [Related]
18. Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess.
Talan DA; Mower WR; Krishnadasan A; Abrahamian FM; Lovecchio F; Karras DJ; Steele MT; Rothman RE; Hoagland R; Moran GJ
N Engl J Med; 2016 Mar; 374(9):823-32. PubMed ID: 26962903
[TBL] [Abstract][Full Text] [Related]
19. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876
[TBL] [Abstract][Full Text] [Related]
20. Use of administrative healthcare claims to examine the effectiveness of trimethoprim-sulfamethoxazole versus fluoroquinolones in the treatment of community-acquired acute pyelonephritis in women.
Carrie AG; Metge CJ; Collins DM; Harding GK; Zhanel GG
J Antimicrob Chemother; 2004 Mar; 53(3):512-7. PubMed ID: 14749344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
